Communiqués Prenetics Global Limited

Actions

PRE

KYG722451229

Equipement, fournitures et distribution médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 06/07/2026			Varia. 5j.	Varia. 1 janv.
17,49 ^USD	+3,31%		-5,87%	+11,05%

16/06	PRENETICS GLOBAL LIMITED : Opinion positive de Benchmark Company	ZM
10/06	Prenetics Global Limited publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Communiqués

10/06	Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue	AQ
04/06	Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion	AQ
20/05	Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership	AQ
14/05	Prenetics Global : 1Q26 Earnings Presentation	PU
14/05	Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8	AQ
14/05	Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M	AQ
08/05	Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call	AQ
07/05	Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership	AQ
14/04	Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One	AQ
02/04	Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership	AQ
24/03	Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation	AQ
18/03	Prenetics to Participate in the 38th Annual ROTH Conference	AQ
06/03	Prenetics Authorizes $40 Million Share Repurchase Program	AQ
03/03	Prenetics Executives Execute Second Consecutive Round of Post-Earnings Open Market Share Purchases of $1.3 Million— Cumulative Personal Investment Across Both Rounds Reaches $2.7 Million	AQ
23/02	Prenetics Launches IM8 Daily Ultimate Essentials PRO — A Clinical Formula with Two New Flavours	AQ
18/02	Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY	AQ
17/02	Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors	AQ
17/02	Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity	AQ
13/02	Formula 1 Phenom Ollie Bearman Joins Prenetics’ IM8 Health as Global Ambassador and Shareholder	AQ
11/02	Prenetics to Report Q4 and Full Year 2025 Financial Results on Feb 18, 2026 and Host Earnings Conference Call	AQ
06/01	Prenetics Reinforces Strategic Focus on IM8, Divests Europa Business For Up to $13 Million	AQ
05/01	Prenetics Provides Update on Voluntary Warrant Exchange Program, Reaching 86.7% Participation	AQ
30/12	Prenetics Announces Update to Capital Allocation Strategy; Ceases Bitcoin Purchases to Focus on IM8	AQ
23/12	Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure	AQ
25/11	Prenetics Announces Upcoming Conference Participation	AQ